Skip to main content
. 2024 Apr 18;19:50. doi: 10.1186/s13014-024-02439-0

Fig. 1.

Fig. 1

Consort diagram. (In total, 238 patients with ES-NSCLC were recommended for SABR. Patients with PS > 2, operable or with history of cancer were excluded from the study. Finally 172 patients were analyzed)